Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice
Explore this paper's citation graph
Summary
It is demonstrated for the first time in normal inbred mice that lifespan can be extended by rapamycin, and opens an avenue to develop optimal doses and schedules of rap amycin as an anti-aging modality.
- Type
- article
- Published
- 2011-12-15
- Cited by
- 329
- References
- 52
- Access
- Open access
- OpenAlex
- https://openalex.org/W2009602165
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:207511877
Keywords
Biology, Longevity, mTORC1, Carcinogenesis, Sirolimus
References
- Extension of chronological life span by reduced TOR signaling requires down-regulation of Sch9p and involves increased mitochondrial OXPHOS complex density
- TOR signaling in growth and metabolism.
- The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway
- Quantifying pharmacologic suppression of cellular senescence: prevention of cellular hypertrophy versus preservation of proliferative potential
- mTOR's role in ageing: protein synthesis or autophagy?
- If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice
- The mitochondrial ribosomal protein of the large subunit, Afo1p, determines cellular longevity through mitochondrial back-signaling via TOR1
- Metformin and sex: why suppression of aging may be harmful to young male mice
- Effect of Epithalon on the Incidence of Chromosome Aberrations in Senescence-Accelerated Mice
- mTOR pathway activation in age-related retinal disease
- Pharmacological Inhibition of Phosphoinositide 3 and TOR Kinases Improves Survival of Drosophila melanogaster
- Paradoxical suppression of cellular senescence by p53
- Rapamycin decelerates cellular senescence
- Rapamycin and quasi-programmed aging: Four years later
- Growth stimulation leads to cellular senescence when the cell cycle is blocked
- Fighting neurodegeneration with rapamycin: mechanistic insights
- Prevention of cancer by inhibiting aging
- Ribosomal protein S6 kinase 1 signaling regulates mammalian lifespan
- Metformin Decelerates Aging and Development of Mammary Tumors in HER-2/neu Transgenic Mice
- Aging and Immortality: Quasi-Programmed Senescence and Its Pharmacologic Inhibition
Cited by
- Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance
- Energy metabolism and metabolic sensors in stem cells: the metabostem crossroads of aging and cancer.
- Answering the ultimate question “What is the Proximal Cause of Aging?”
- Rapamycin Combined with Immature Dendritic Cells Attenuates Obliterative Bronchiolitis in Trachea Allograft Rats by Regulating the Balance of Regulatory and Effector T Cells
- Rapamycin, proliferation and geroconversion to senescence
- M(o)TOR of aging: MTOR as a universal molecular hypothalamus
- ANALYSIS OF THE ROLE OF TWO AUTOPHAGY PATHWAY RELATED GENES, BECN1 AND TSC1, IN MURINE MAMMARY GLAND DEVELOPMENT AND DIFFERENTIATION
- Mouse models and aging: longevity and progeria.
- The role of telomerase in brain during ageing and under dietary restriction
- Health Effects of Long-Term Rapamycin Treatment: The Impact on Mouse Health of Enteric Rapamycin Treatment from Four Months of Age throughout Life
- SKN-1/Nrf, stress responses, and aging in Caenorhabditis elegans
- Conservative growth hormone/IGF-1 and mTOR signaling pathways as a target for aging and cancer prevention: do we really have an antiaging drug?
- Rapamycin increases oxidative stress response gene expression in adult stem cells
- Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to
- Molecular damage in cancer: an argument for mTOR-driven aging
- One-carbon metabolism: An aging-cancer crossroad for the gerosuppressant metformin
- Rejuvenating immunity: “anti-aging drug today” eight years later
- Mechanistic or mammalian target of rapamycin (mTOR) may determine robustness in young male mice at the cost of accelerated aging
- Herbal Therapeutics that Block the Oncogenic Kinase PAK1: A Practical Approach towards PAK1‐dependent Diseases and Longevity
- NCI's provocative questions on cancer: some answers to ignite discussion
Related papers
- Population Attributable Fractions for Modifiable Factors of Longevity and Healthy Longevity Among the Late-Elderly Aged 75 Years or Older — China, 1998–2018
- Influence of Temperature and Nutrition on Adult Longevity of Microplitis tuberculiferWesmael
- Brain and Longevity
- On Comparative Longevity in Man and the Lower Animals
- Does dietary restriction really increase longevity in Drosophila melanogaster?
- Influence of diet on survival of mice.